159. 色素性乾皮症 Disease details / Clinical trials / Drug dev / DR info

臨床試験数 : 11 / 薬物数 : 11 - (DrugBank : 5) / 標的遺伝子数 : 5 - 標的パスウェイ数 : 16

薬物、開発者（Primary Sponsor）、臨床試験情報（症例登録開始年（Enrollment year）、フェーズ、ID、実施国）
Afamelanotide
   CLINUVEL EUROPE LIMITED
      2022   Phase 2   EUCTR2021-001419-10-ES   Belgium;Spain
      2022   Phase 2   EUCTR2021-001419-10-BE   Belgium;Spain
      2021   Phase 2   EUCTR2019-000597-34-DE   Germany
   CLINUVEL EUROPE LTD
      2021   Phase 2   EUCTR2021-003642-20-DE   Germany
   Clinuvel Europe Limited
      2022   Phase 2   NCT05370235   Belgium;Spain
      2021   Phase 2   NCT05159752   Germany
Biospecimen collection
   National Cancer Institute (NCI)
      2021   Phase 1   NCT04500548   Canada;United States
Ipilimumab
   National Cancer Institute (NCI)
      2021   Phase 1   NCT04500548   Canada;United States
Isotretinoin
   National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
      1991   -   NCT00025012   United States
Liposomal T4n5 lotion
   Applied Genetics
      1996   Phase 3   NCT00002811   Germany;United Kingdom;United States
Nivolumab
   National Cancer Institute (NCI)
      2021   Phase 1   NCT04500548   Canada;United States
Scenesse
   CLINUVEL EUROPE LIMITED
      2022   Phase 2   EUCTR2021-001419-10-ES   Belgium;Spain
      2022   Phase 2   EUCTR2021-001419-10-BE   Belgium;Spain
      2021   Phase 2   EUCTR2019-000597-34-DE   Germany
   CLINUVEL EUROPE LTD
      2021   Phase 2   EUCTR2021-003642-20-DE   Germany
Trabectedina
   PharmaMar S.A. Sociedad Unipersonal
      2011   Phase 2   EUCTR2010-022968-13-ES   Belgium;Spain
Trabectedine
   Pharma Mar, S.A. Sociedad Unipersonal
      2011   Phase 2   EUCTR2010-022968-13-BE   Belgium;Spain
Yondelis 0,25 MG polvo para concentrado para solucióN para perfusióN
   PharmaMar S.A. Sociedad Unipersonal
      2011   Phase 2   EUCTR2010-022968-13-ES   Belgium;Spain
Yondelis 1 MG polvo para concentrado para solucióN para perfusióN
   PharmaMar S.A. Sociedad Unipersonal
      2011   Phase 2   EUCTR2010-022968-13-ES   Belgium;Spain